VPIM
VRCA icon

Vanguard Personalized Indexing Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,807
Closed -$12.6K – 1909
2024
Q4 		$12.6K Buy
+1,807
New +$19.9K ﹤0.01% 1796

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return

Vanguard Personalized Indexing Management's VRCA Position: Q1 2025 in Review

Vanguard Personalized Indexing Management sold out of Verrica Pharmaceuticals (VRCA) in Q1 2025, closing a stake of 1,807 shares — an estimated $12.6K sold.

Vanguard Personalized Indexing Management first reported a position in VRCA in Q4 2024 and held it in 1 quarter. The position peaked at $12.6K in Q4 2024. 74 funds tracked by Wall St. Rank hold VRCA as of Q1 2025.

  • Vanguard Personalized Indexing Management reported no remaining Verrica Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 1,807 Verrica Pharmaceuticals shares in Q1 2025, an estimated $12.6K.
  • Vanguard Personalized Indexing Management first reported a position in Verrica Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Verrica Pharmaceuticals position peaked at $12.6K in Q4 2024.
  • 74 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2025, filed 14 May 2025.